THE QUESTION Hair loss in men shares some risk factors with pro state cancer. Both are more common with aging and when there’s a family history of the condition. Also, a hormone that’s a derivative of testosterone plays a role in both. Might there be a further connection between baldness and prostate cancer? Read full article >>
Prostate cancer is the most diagnosed cancer type in the U.S., with nearly 239,000 new cases diagnosed in 2013. Find out what existing and developing pharmaceutical products are being used to improve patients' overall survival and quality of life and where the disease is most prominent.
Over 2 million American men alive today are prostate cancer survivors — making prostate cancer one of the most common cancer diagnoses in men, second only to skin cancer.
By Prohost Biotech: Tokai Pharmaceuticals, Inc., (NASDAQ:TKAI) is a clinical-stage biopharmaceutical company focused on developing novel therapies for prostate cancer and other hormonally-driven diseases. Tokai announced the pricingShow More Summary
A few years ago, women were usually told to get annual mammograms starting at age 40, and men were told that the PSA blood test for prostate cancer was a lifesaver. Now the U.S. Preventive Services Task Force, whose advice helps setShow More Summary
The effect of guidelines recommending that elderly men should not be routinely screened for prostate cancer "has been minimal at best," according to a new study led by researchers at Henry Ford Hospital.
Relax, male cyclists. Riding a bike won't give you ED -- but it is correlated with a higher risk of prostate cancer
23 new regions of the genome have been discovered that influence the risk for developing prostate cancer, according to a study. Prostate cancer is the most common non-skin cancer in American men. About 1 in 6 men will be diagnosed with the disease in his lifetime. Show More Summary
In preclinical animal models of metastatic prostate cancer, scientists at VCU Massey Cancer Center and Johns Hopkins Medical Institutions have developed a new molecular imaging approach that could revolutionize doctors' ability to see tumors that have metastasized to other sites in the body, including the bones.
Some treatments for prostate cancer, while initially effective at controlling the disease, not only stop working over time but actually start driving tumour growth, a major new study shows. Researchers identified the emergence of drug-resistant...Show More Summary
In an analysis of genetic information among more than 87,000 men, a global team of scientists says it has found 23 new genetic variants – common differences in the genetic code -- that increase a man's risk for prostate cancer. The so-called...Show More Summary
In an analysis of genetic information among more than 87,000 men, a global team of scientists says it has found 23 new genetic variants - common differences in the genetic code -- that increase a man's risk for prostate cancer. The so-called...Show More Summary
Researchers at Moffitt Cancer Center, including Center Director Thomas A. Sellers, Ph.D., M.P.H., Jong Park, Ph.D. and Hui-Yi Lin, Ph.D., have discovered 23 new regions of the genome that influence the risk for developing prostate cancer, according to a study published Sept. 14 in Nature Genetics.
Rutgers Cancer Institute of New Jersey is one of numerous worldwide sites to offer a clinical trial examining the investigational vaccine-based treatment PROSTVAC in patients with prostate cancer that is no longer responsive to hormone therapy and has spread (metastasized) to other parts of the body. Show More Summary
A consortia of research hubs around the world encompassing 150 researchers has analysed more than 10 million genetic markers in 80,000 men with prostate cancer. "We now have 100 genetic regions and no other cancer has had this many loci identified to be associated with it. Show More Summary
It’s been a bad news week for sports. Here’s a bit of good news.
Male-pattern baldness is connected to aggressive prostate cancer, according to new research in the Journal of Clinical Oncology.
Men with prostate cancer may one day be able to predict when and how much various treatments will impact their urinary and sexual functioning, thanks in part to new findings that researchers at Fox Chase Cancer Center presented at the American Society for Radiation Oncology's 56th Annual Meeting on Tuesday, September 16. read more
Men who experience baldness in both the crown and front of their heads at age 45 are more likely to develop an aggressive form of prostate cancer later in life, a new study found. Both prostate cancer and the very specific pattern of baldness may be related to increased levels of male sex hormones and receptors. Show More Summary
Scientists could soon better predict a man's risk of getting prostate cancer after a worldwide team of researchers carried out the largest-ever analysis of the cancer's genetic biomarkers, reported in Nature Genetics today. QUT Institute...Show More Summary